UNSPSC 51281720: Talampicillin hydrochloride

This classification denotes an anti-bacterial agent and ampicillin C24H23N3O6S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4C5O3X072I, chemically known as (2s,5r,6r)-6-((r)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid ester with 3-hydroxyphthalide, monohydrochloride, but more generally known as talampicillin hydrochloride, which bears US NIH Compound Identifier 71446.

UNSPSC 51281720 Talampicillin hydrochloride is a Commodity code for a specific antibiotic pharmaceutical product, yet the recent state and local opportunities tagged under it show minimal activity directly aligned with this narrow scope. The two recent records in the database reflect pharmaceutical procurement by state health departments and county public health agencies, but neither opportunity actually involves talampicillin hydrochloride — the Illinois Department of Public Health awarded a completed piggyback contract through MMCAP Infuse to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets, while Seminole County, Florida solicited Naloxone and drug deactivation systems. The code appears to be a placeholder or incorrectly applied tag in the state and local procurement database, as the actual pharmaceutical goods being purchased fall under different commodity codes.

Activity under this code is limited to health-focused government agencies in Florida and Illinois as of mid-2026. The Illinois Department of Public Health contract, awarded on August 28, 2026, represents a $2,999,999.11 multi-year pharmaceutical supply award with an initial 12-month term and two renewal years; Seminole County's IFB 60459723LAS, posted June 30, 2026 with a July 26, 2023 response deadline, sought annual quantities of 1,900 units of Naloxone and 800 drug deactivation systems for quarterly delivery. Neither solicitation is substantively related to talampicillin hydrochloride procurement. Vendors pursuing this code should verify the actual pharmaceutical products required rather than relying on the code assignment, as recent state and local demand does not align with talampicillin supply.